Switch theme
Sign up to access all valuation multiples
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.
1985
n/a
LTM Revenue $102M
LTM EBITDA -$11.2M
$373M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Binex has a last 12-month revenue of $102M and a last 12-month EBITDA of -$11.2M.
In the most recent fiscal year, Binex achieved revenue of $88.6M and an EBITDA of -$16.5M.
Binex expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Binex valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $105M | $88.6M | XXX | XXX | XXX |
| Gross Profit | $48.0M | $38.8M | XXX | XXX | XXX |
| Gross Margin | 46% | 44% | XXX | XXX | XXX |
| EBITDA | $11.4M | -$16.5M | XXX | XXX | XXX |
| EBITDA Margin | 11% | -19% | XXX | XXX | XXX |
| Net Profit | $8.5M | $3.2M | XXX | XXX | XXX |
| Net Margin | 8% | 4% | XXX | XXX | XXX |
| Net Debt | $15.7M | $26.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Binex's stock price is KRW 16460 (or $11).
Binex has current market cap of KRW 509B (or $347M), and EV of KRW 547B (or $373M).
See Binex trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $373M | $347M | XXX | XXX | XXX | XXX | $-0.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Binex has market cap of $347M and EV of $373M.
Binex's trades at 3.7x LTM EV/Revenue multiple, and -33.2x LTM EBITDA.
Analysts estimate Binex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Binex and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $373M | XXX | XXX | XXX |
| EV/Revenue | 4.2x | XXX | XXX | XXX |
| EV/EBITDA | -22.6x | XXX | XXX | XXX |
| P/E | -14.5x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -26.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBinex's NTM/LTM revenue growth is 40%
Binex's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Binex's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Binex's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Binex and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -16% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -244% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 22% | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 25% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 40% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Binex acquired XXX companies to date.
Last acquisition by Binex was XXXXXXXX, XXXXX XXXXX XXXXXX . Binex acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Binex founded? | Binex was founded in 1985. |
| Where is Binex headquartered? | Binex is headquartered in South Korea. |
| Who is the CEO of Binex? | Binex's CEO is Mr. Hyuk-jong Lee. |
| Is Binex publicy listed? | Yes, Binex is a public company listed on KRX. |
| What is the stock symbol of Binex? | Binex trades under 053030 ticker. |
| When did Binex go public? | Binex went public in 2001. |
| Who are competitors of Binex? | Similar companies to Binex include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Binex? | Binex's current market cap is $347M |
| What is the current revenue of Binex? | Binex's last 12-month revenue is $102M. |
| What is the current EBITDA of Binex? | Binex's last 12-month EBITDA is -$11.2M. |
| What is the current EV/Revenue multiple of Binex? | Current revenue multiple of Binex is 3.7x. |
| What is the current EV/EBITDA multiple of Binex? | Current EBITDA multiple of Binex is -33.2x. |
| What is the current revenue growth of Binex? | Binex revenue growth between 2023 and 2024 was -16%. |
| Is Binex profitable? | Yes, Binex is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
